Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...

Anyone living with sickle cell anemia is a warrior, Leslie Davis-Primo will tell you. “I’ve had three children, largely ...

Researchers have discovered that a person's "bioenergetic age," reflecting how efficiently cells produce energy, strongly ...

A Long Island hospital has successfully treated Sebastien Beauzile, a 21-year-old from Laurelton, with the groundbreaking ...

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...

Parkinson's cases are set to double by 2050. Learn why it's rising and how lifestyle changes can support long-term brain ...

Data on the number of cases for these diseases from the pre-vaccine era is hard to come by, and even the case counts are ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Learn the essential early warning signs of leukemia that are often dismissed as everyday ailments but could be indicators of ...

In humans and other multicellular organisms, cells multiply. This defining feature allows embryos to grow into adulthood, and ...